Senseonics, Welldoc Team Up on Next-Gen Eversense 365 App

Senseonics and Welldoc, a leader in artificial intelligence (AI)-powered health solutions, began a strategic partnership to develop a new custom mobile application for the Eversense 365 implantable continuous glucose monitoring (CGM) system.

The next-gen app will maintain all existing features, with new features to boost user experience and facilitate better integration with popular digital health tools. The new Eversense 365 app will integrate with Apple Health and Google Health Connect so users can compile their most valuable health and fitness data into one place.

The app will also continue to support the combination of Eversense 365 with the twiist automated insulin delivery (AID) system, which launched in the U.S. earlier this year.

The app will also boast a revamped interface with improved visual components and workflows for all features and functions of the current app. The duo’s project will focus on enhancing the user interface and experience of sensor and transmitter integration, including pairing and activation, communication status, synchronization, data displays and alerts.

It’s expected to launch in the U.S. during the second half of this year and become available in European markets early next year. After launching the app, Senseonics and Welldoc plan to collaborate on a cadence of future app releases—the duo believes the enhancements could include CGM-informed bolus calculation, medication management, metabolic tracking and logbook, and educational resources.

Comments from Senseonics and Welldoc

Tim Goodnow, CEO, Senseonics: “At Senseonics we’re committed to making the CGM experience as convenient and effective as possible, with excellence at the heart of everything we do. This makes Welldoc a natural partner for developing our next-generation app and we look forward to leveraging their platform and expertise in AI-powered digital health. Eversense 365 has an exceptional track record of customer satisfaction, and we are always listening to patients so that we can improve the user experience. Our app will now evolve to make living with diabetes even easier, with better functionality, new features and enhanced integration with the digital health ecosystem.”

Kevin McRaith, president and CEO, Welldoc: “We are pleased to enter this partnership with Senseonics, which brings together two companies that are resolutely focused on improving patient experience and outcomes in chronic care. Eversense 365 is highly advanced technology that deserves an app to match its unique patient proposition and disruptive potential. The new app will benefit from Welldoc’s deep domain expertise, healthcare-ready AI capabilities and broader digital health platform, to offer patients a best-in-class user experience and better interoperability with popular health tools.”